McKesson is paying up to $7.4 billion over opioid distribution, and admits nothing.

By ··1 min read·2 sources

The largest distributor's share of the national settlement runs for 18 years. None of it goes to individual patients.

McKesson, Cardinal Health and AmerisourceBergen approved the national opioid settlement in February 2022, effective April 2. The three pay up to about $19.5 billion over 18 years. McKesson's share is up to $7.4 billion.

Forty-six of 49 eligible states joined. The distributors do not admit liability or wrongdoing, and said they continue to strongly dispute the allegations. At least 85% of the money must go to state and local remediation.

One term describes the failure better than the dollar figure. The distributors must build a clearinghouse pooling their controlled-substance shipment data. Until this settlement, no one could see outsize orders across the three companies that move most of the country's drugs.

Spread over 18 years, $7.4 billion is a manageable annual cost for a company of McKesson's size. The settlement resolves claims that it shipped volume without a system to stop it. It does so without a finding that it did.

Sources

  1. sec.gov · sec.gov/Archives/edgar/data/927653/000092765322000024/ex992pressrelease-jointnew.htm
  2. sec.gov · sec.gov/Archives/edgar/data/927653/000092765323000017/mck-20221231.htm

Cite this report

The Precedent. "McKesson is paying up to $7.4 billion over opioid distribution, and admits nothing.." October 4, 2026. https://theprecedent.org/article/mckesson-is-paying-up-to-74-billion-over-opioid-distribution-and-admits-nothing

Companies in this report